Compound 451238 / Merck (MSD), Royal Marsden Hospital  >>  Phase 2
Welcome,         Profile    Billing    Logout  

1 Trials

Remove FilterRemove Filter

 
Trial + Data / EventsStatusPhNRegionInterventionsSponsorConditionsPrimary complStudy compl
Compound 451238 / Royal Marsden Hospital
NCT03602833: Phase I Study Compound 451238 and Radiotherapy in Soft-tissue Sarcoma

Active, not recruiting
1/2
12
Europe
Compound 451238
Royal Marsden NHS Foundation Trust, Merck KGaA, Darmstadt, Germany
Soft-tissue Sarcoma
05/22
01/23

Download Options